Dennis A. Revicki
Center for Health Outcome Research
MEDTAP International
Inc., Bethesda
MD 20814
USA
Name/email consistency: high
- Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. Revicki, D.A., Hirschfeld, R.M., Ahearn, E.P., Weisler, R.H., Palmer, C., Keck, P.E. J. Affect. Disord (2005)
- Patient assessment of treatment satisfaction: methods and practical issues. Revicki, D.A. Gut (2004)
- Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Revicki, D.A., Rentz, A.M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N.J., Tack, J. Qual. Life. Res (2004)
- Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Revicki, D.A., Rentz, A.M., Tack, J., Stanghellini, V., Talley, N.J., Kahrilas, P., De La Loge, C., Trudeau, E., Dubois, D. Clin. Gastroenterol. Hepatol. (2004)
- Cost-effectiveness and HRQOL outcomes of divalproex sodium (Depakote(R)) in bipolar disorder. Revicki, D.A. Expert. Rev. Pharmacoecon. Outcomes. Res (2004)
- Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. Revicki, D.A., Paramore, L.C., Sommerville, K.W., Swann, A.C., Zajecka, J.M. J. Clin. Psychiatry (2003)
- Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Revicki, D.A., Rentz, A.M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N.J., Tack, J. Aliment. Pharmacol. Ther. (2003)
- Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Revicki, D.A., Zodet, M.W., Joshua-Gotlib, S., Levine, D., Crawley, J.A. Health. Qual. Life. Outcomes (2003)
- Imputing physical health status scores missing owing to mortality: results of a simulation comparing multiple techniques. Revicki, D.A., Gold, K., Buckman, D., Chan, K., Kallich, J.D., Woolley, J.M. Med. Care (2001)
- Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence. Revicki, D.A. Curr. Opin. Investig. Drugs (2001)
- The new atypical antipsychotics: a review of pharmacoeconomic studies. Revicki, D.A. Expert. Opin. Pharmacother (2000)
- Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Revicki, D.A., Osoba, D., Fairclough, D., Barofsky, I., Berzon, R., Leidy, N.K., Rothman, M. Qual. Life. Res (2000)
- Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies. Revicki, D.A. J. Clin. Psychiatry (1999)
- Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia. Revicki, D.A. Schizophr. Res. (1999)
- Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. Revicki, D.A., Moyle, G., Stellbrink, H.J., Barker, C. AIDS (1999)
- Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. Revicki, D.A., Frank, L. Pharmacoeconomics (1999)
- Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Revicki, D.A., Crawley, J.A., Zodet, M.W., Levine, D.S., Joelsson, B.O. Aliment. Pharmacol. Ther. (1999)
- Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. Revicki, D.A., Swartz, C., Wu, A.W., Haubrich, R., Collier, A.C. Antivir. Ther. (Lond.) (1999)
- Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Revicki, D.A., Leidy, N.K., Brennan-Diemer, F., Thompson, C., Togias, A. Qual. Life. Res (1998)
- Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. Revicki, D.A., Wood, M. J. Affect. Disord (1998)
- Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Revicki, D.A., Leidy, N.K., Brennan-Diemer, F., Sorensen, S., Togias, A. Chest (1998)
- Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Revicki, D.A., Sorensen, S., Maton, P.N., Orlando, R.C. Dig. Dis (1998)
- Work-related stress and psychological distress in emergency medical technicians. Revicki, D.A., Gershon, R.R. J. Occup. Health. Psychol (1996)